Month: May 2021

PONTE VEDRA, Fla., May 25, 2021 (GLOBE NEWSWIRE) — Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a commercial-stage orthopaedic medical device company driving a paradigm shift in the surgical treatment of Hallux Valgus (commonly known as bunions), today reported financial results for the first quarter ended March 31, 2021. Recent Highlights:Revenue of $18.7 million, a 66% increase over the same period last year Gross margin of 82.2%, an increase of 340 basis points from the same period last year Completed initial public offering with $107.1 million in proceeds, net of underwriting discounts, commissions and offering costs Interim results from ALIGN3D™ clinical study demonstrating positive radiographic and patient-reported outcomes starting at 6 weeks and maintained at 12 months“We are pleased to...

Third Quarter HighlightsRevenue grows 60% year-over-year to $176.4 million Calculated billings grows 71% year-over-year to $225.0 million Deferred revenue grows 65% year-over-year to $495.4 million GAAP net loss of $58.5 million compared to GAAP net loss of $19.3 million on a year-over-year basis Non-GAAP net income of $21.4 million compared to non-GAAP net income of $10.3 million on a year-over-year basisSAN JOSE, Calif., May 25, 2021 (GLOBE NEWSWIRE) — Zscaler, Inc. (Nasdaq: ZS), the leader in cloud security, today announced financial results for its third quarter of fiscal year 2021, ended April 30, 2021. “We delivered outstanding results for the third quarter, with revenue growth accelerating to 60% year over year and free cash flow reaching a new record. Our Zero Trust Exchange platform is helping customers realize...

CSWC Reports Pre-Tax Net Investment Income of $0.44 Per Share for the Quarter Ended March 31, 2021 and Increases Regular Dividend to $0.43 Per Share DALLAS, May 25, 2021 (GLOBE NEWSWIRE) — Capital Southwest Corporation (“Capital Southwest,” “CSWC” or the “Company”) (Nasdaq: CSWC), an internally managed business development company focused on providing flexible financing solutions to support the acquisition and growth of middle market businesses, today announced its financial results for the fourth fiscal quarter and fiscal year ended March 31, 2021. Fourth Quarter Fiscal Year 2021 Financial HighlightsTotal Investment Portfolio: $688.4 millionCredit Portfolio of $572.6 million:92% 1st Lien Secured Debt $74.8 million in new committed credit investments Weighted Average Yield on Debt Investments: 10.8% No investments on non-accrualEquity...

— Substantial Investments in Channel Credit Extensions, a New Gaming Team, An Education Community Engagement Group, and a New Distribution Center Will Mark D&H’s 104th Fiscal Year — HARRISBURG, Pa., May 25, 2021 (GLOBE NEWSWIRE) — D&H Distributing, a major provider of SMB, mid-market, and consumer technologies to the North American channel, announces it has finished its Fiscal Year 2021 on April 30th showing strong growth figures, with full fiscal year growth expected to exceed 19% in the US and 15% in Canada. The company also experienced 34% growth of business through its VAR customer base, and double-digit growth in its consumer sector. D&H Distributing’s combined US and Canadian revenue has now exceeded $5 billion USD. D&H’s proactive, demand-generation business model helped drive the strong growth, supported...

Nicosia, Cyprus, May 25, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Rafina Innovations Inc. (OTC PINK: VICA), a Medical and Pharmaceutical development company, is pleased to announce C-Pharm’s 1st Quarter -31 March, 2021- revenues for 2021 are $1.7 Million US dollars. Rafina’s CEO stated, “Over a year into the pandemic, C-Pharm managed to increase its revenues from $700,000 within the first quarter of 2020 to $1.7 million in the first quarter of 2021, by acquiring new business strategies, expanding in new territories and creating new opportunities during difficult times. We have significantly increased our distribution and sale in pharmaceutical products throughout Europe. The next goal is to expand further into the Europe – Asia territories.” C-Pharm’s unique business model allows Rafina to...